This is the authors' abstract. We don't add key points for this paper.
Marking nodes with biopsy-confirmed metastatic disease allows for selective removal and improves pathologic evaluation for residual nodal disease after chemotherapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Caudle et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: